Skip to main content
. 2022 Feb 2;13:817556. doi: 10.3389/fneur.2022.817556

Table 1.

Demographic and clinical features of all participants.

Characteristics HC (n = 92) Active CD (n = 58) Inactive CD (n = 57) P value
Gender (M/F) 66:26 47:11 44:13 0.435b
Age (years) 28.65 ± 9.49 30.09 ± 11.23 32.56 ± 11.32 0.090a
Education (years) 17.40 ± 2.53 16.80 ± 2.11 16.9 ± 2.51 0.261a
BMI 19.98 ± 3.37 19.80 ± 3.68 20.00 ± 4.10 0.946a
Duration (years) 1.23 ± 1.11 1.67 ± 1.51 0.077c
CDAI 284.22 ± 38.23 86.51 ± 26.93 <0.001c*
SES-CD 13.86 ± 7.03 2.81 ± 1.74 <0.001c*
CRP 25.37 ± 30.04 10.15 ± 17.01 <0.001c*
ESR 21.90 ± 19.58 12.68 ± 14.51 0.012c*
PLT 300.83 ± 111.67 265.52 ± 109.77 0.700c
Montreal classification
L1:L2:L3:L4 14:7:33:4 12:6:36:3 0.920b
B1:B2:B3:P 14:18:26:29 21:12:24:23 0.379b

The values are presented as mean values ± standard deviations.

HC, healthy controls; CD, Crohn's disease; BMI, Body Mass Index; CDAI, Crohn's disease Activity Index; SES-CD, Simple endoscopic score for Crohn's disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; PLT, platelet levels; L1, ileum; L2, colonic; L3, ileocolonic; L4, upper gastrointestinal tract disease; B1, on inflammatory and no penetrating; B2, inflammatory; B3, penetrating; P, perianal disease.

a

P value for one-way ANOVA.

b

P value for Chi-square test.

c

P value for independent-sample T-test.

*

Significant difference between active CD group and inactive CD group (P <0.05).